NAD+ supplied already in solution — which for a cofactor this unstable is a meaningful difference, not a convenience.
- Contains
- NAD+ (sequence, formula and CAS number are on the vial product page)
- Content
- 750mg in a metered intranasal bottle
- Presentation
- ready-to-use metered intranasal solution; no reconstitution step
- Purity
- ≥99% by HPLC, identity confirmed by mass spectrometry
- Released against
- the Certificate of Analysis for its own batch
About NAD+ Nasal Spray
This supplies nicotinamide adenine dinucleotide in a metered intranasal preparation rather than as a lyophilised powder. The compound is the same redox cofactor consumed by sirtuins, PARPs and CD38.
For NAD+ specifically, arriving in a prepared and verified solution addresses the compound’s main practical weakness. NAD+ hydrolyses in aqueous solution at a rate that depends on pH and temperature, so a solution buffered and filled under controlled conditions is in better shape than one made up at the bench from hygroscopic powder.
What the research covers
The research context matches the powder: sirtuin-dependent signalling, PARP-mediated DNA repair, and the question of raising intracellular concentration. The NAD+ page covers the literature, including the important distinction between applying the cofactor and applying a precursor.
Where the intranasal route is itself part of the design, this is the relevant presentation; where concentration must be set by the protocol, the powder gives that control. The longevity research peptides hub sets out the four separate hypotheses this group covers.
Handling NAD+ Nasal Spray
Supplied as a metered preparation, so there is no reconstitution step — which for this compound removes the step most likely to introduce error.
Keep cold, upright and out of light, and treat the usable life as genuinely limited rather than nominal: unlike a sealed peptide vial, this solution is degrading from the day it is filled, and the hydrolysis products are not inert.
Other formats
The same compound is supplied as a lyophilised NAD+ vial, which gives control over concentration that a fixed solution cannot.
Common questions about NAD+ Nasal Spray
Is this the same compound as the NAD+ vial?
Yes. The compound is identical; it is supplied already in solution in a metered intranasal bottle instead of as a lyophilised powder.
When is the nasal spray the better choice?
When the intranasal route is itself part of the study design, or when consistency between sessions matters more than control over concentration.
When is the vial the better choice?
When the protocol needs to set its own concentration or run dose-ranging. A fixed-concentration solution cannot be varied.
How long does the spray remain usable?
A peptide in solution has a shorter usable life than a sealed lyophilised vial. Keep the bottle cold, upright and protected from light, and treat its life as limited.
